The future of the global prostate health market looks promising with opportunities in pharmacies and e-commerce stores. The global prostate health market is expected to reach an estimated $58.9 billion by 2028 with a CAGR of 9.1% from 2023 to 2028. The major drivers for this market are growing prevalence of benign prostatic hyperplasia and cancer, rising number of prostatitis, and increasing fund for research in BPH treatment.
A more than 150-page report is developed to help in your business decisions.
Answer: The global prostate health market is expected to reach an estimated $58.9 billion by 2028.
Q2. What is the growth forecast for prostate health market?
Answer: The global prostate health market is expected to grow with a CAGR of 9.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the prostate health market?
Answer: The major drivers for this market are growing prevalence of benign prostatic hyperplasia and cancer, rising number of prostatitis, and increasing fund for research in BPH treatment.
Q4. What are the major segments for prostate health market?
Answer: The future of the prostate health market looks promising with opportunities in pharmacies and e-commerce stores.
Q5. Who are the key prostate health companies?
Answer: Some of the key prostate health companies are as follows:
Answer: The analyst forecasts that prostate cancer will remain the largest disease indication segment over the forecast period because augmenting cancer cases has influenced the usage of immunotherapies to inhibit prostate cancer cells from spreading. Also, hormone therapy is generally used to effectively treat cancer at the initial stage.
Q7. In prostate health market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region due to presence of advanced prostate treatment facilities, rising awareness towards prostate health, and growing cases of BPH and prostate cancer in the region.
Q8. Do we receive customization in this report?
Answer: Yes, the analyst provides 10% Customization Without any Additional Cost.
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?
This product will be delivered within 1-3 business days.
A more than 150-page report is developed to help in your business decisions.
Prostate Health Market by Segment
The study includes trends and forecast for the global prostate health market by disease indication, treatment outlook, distribution channel, and region, as follows:Prostate Health Market by Disease Indication [Value ($B) Shipment Analysis from 2017 to 2028]:
- Prostate Cancer
- Prostatitis
- Alpha Blockers
- Benign Prostate Hyperplasia
- Others
Prostate Health Market by Treatment Outlook [Value ($B) Shipment Analysis from 2017 to 2028]:
- Cytotoxic Agents
- Hormone ADT
- AR Directed Therapies
- PARP Inhibitors
- Others
Prostate Health Market by Distribution Channel [Value ($B) Shipment Analysis from 2017 to 2028]:
- Pharmacy
- E-Commerce Stores
- Others
Prostate Health Market by Region [Value ($B) Shipment Analysis from 2017 to 2028]:
- North America
- Europe
- Asia Pacific
- The Rest of the World
List of Prostate Health Companies
Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies, prostate health companies cater to increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the prostate health companies profiled in this report include-- Eli Lilly and Company
- Pfizer
- Merck & Co.
- Abbott
- Endo Pharmaceuticals
- GlaxoSmithKline PLC
- Siemens Healthcare
- Amgen
- AstraZeneca
Prostate Health Market Insights
- The analyst forecasts that prostate cancer will remain the largest disease indication segment over the forecast period because augmenting cancer cases has influenced the usage of immunotherapies to inhibit prostate cancer cells from spreading. Also, hormone therapy is generally used to effectively treat cancer at the initial stage.
- E-commerce store segment is expected to record the highest growth because they are user-friendly. Moreover, they expand quickly and have begun to replace conventional medical stores. Using e-pharmacy to purchase medicines is simple and useful for persons who live far away and also helps to save time and money.
- North America is expected to remain the largest region due to presence of advanced prostate treatment facilities, rising awareness towards prostate health, and growing cases of BPH and prostate cancer in the region.
Features of the Prostate Health Market
- Market Size Estimates: Prostate health market size estimation in terms of value ($B)
- Trend And Forecast Analysis: Market trends (2017-2022) and forecast (2023-2028) by various segments and regions.
- Segmentation Analysis: Prostate health market size by various segments, such as by disease indication, treatment outlook, distribution channel, and region
- Regional Analysis:Prostate health market breakdown by North America, Europe, Asia Pacific, and the Rest of the World.
- Growth Opportunities: Analysis on growth opportunities in different disease indications, treatment outlooks, distribution channels, and regions for the prostate health market.
- Strategic Analysis: This includes M&A, new product development, and competitive landscape for the prostate health market.
- Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
FAQS
Q1. What is the prostate health market size?Answer: The global prostate health market is expected to reach an estimated $58.9 billion by 2028.
Q2. What is the growth forecast for prostate health market?
Answer: The global prostate health market is expected to grow with a CAGR of 9.1% from 2023 to 2028.
Q3. What are the major drivers influencing the growth of the prostate health market?
Answer: The major drivers for this market are growing prevalence of benign prostatic hyperplasia and cancer, rising number of prostatitis, and increasing fund for research in BPH treatment.
Q4. What are the major segments for prostate health market?
Answer: The future of the prostate health market looks promising with opportunities in pharmacies and e-commerce stores.
Q5. Who are the key prostate health companies?
Answer: Some of the key prostate health companies are as follows:
- Eli Lilly and Company
- Pfizer
- Merck & Co.
- Abbott
- Endo Pharmaceuticals
- GlaxoSmithKline PLC
- Siemens Healthcare
- Amgen
- AstraZeneca
Answer: The analyst forecasts that prostate cancer will remain the largest disease indication segment over the forecast period because augmenting cancer cases has influenced the usage of immunotherapies to inhibit prostate cancer cells from spreading. Also, hormone therapy is generally used to effectively treat cancer at the initial stage.
Q7. In prostate health market, which region is expected to be the largest in next 5 years?
Answer: North America is expected to remain the largest region due to presence of advanced prostate treatment facilities, rising awareness towards prostate health, and growing cases of BPH and prostate cancer in the region.
Q8. Do we receive customization in this report?
Answer: Yes, the analyst provides 10% Customization Without any Additional Cost.
This report answers the following 11 key questions
Q.1. What are some of the most promising, high-growth opportunities for the global prostate health market by disease indication (prostate cancer, prostatitis, alpha blockers, benign prostate hyperplasia, and others), treatment outlook (cytotoxic agents, hormone ADT, AR directed therapies, PARP inhibitors, and others), and distribution channel (pharmacy, e-commerce stores, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity did occur in the last five years and how did they impact the industry?
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Global Prostate Health Market: Market Dynamics
3. Market Trends and Forecast Analysis from 2017 to 2028
4. Market Trends and Forecast Analysis by Region from 2017 to 2028
5. Competitor Analysis
6. Growth Opportunities and Strategic Analysis
7. Company Profiles of Leading Players
Companies Mentioned
- Eli Lilly and Company
- Pfizer
- Merck & Co.
- Abbott
- Endo Pharmaceuticals
- GlaxoSmithKline PLC
- Siemens Healthcare
- Amgen
- AstraZeneca
Methodology
The analyst has been in the business of market research and management consulting since 2000 and has published over 600 market intelligence reports in various markets/applications and served over 1,000 clients worldwide. Each study is a culmination of four months of full-time effort performed by the analyst team. The analysts used the following sources for the creation and completion of this valuable report:
- In-depth interviews of the major players in the market
- Detailed secondary research from competitors’ financial statements and published data
- Extensive searches of published works, market, and database information pertaining to industry news, company press releases, and customer intentions
- A compilation of the experiences, judgments, and insights of professionals, who have analyzed and tracked the market over the years.
Extensive research and interviews are conducted in the supply chain of the market to estimate market share, market size, trends, drivers, challenges and forecasts.
Thus, the analyst compiles vast amounts of data from numerous sources, validates the integrity of that data, and performs a comprehensive analysis. The analyst then organizes the data, its findings, and insights into a concise report designed to support the strategic decision-making process.
LOADING...
